Clinical Trial Update: Dose Confirmation Study of Cotara for the Treatment of Glioblastoma Multiforme at First Relapse [Phase 2]

View source ↗

Summary

Phase 2 dose confirmation study of Cotara for glioblastoma at first relapse has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Cotara

Snippet

Sponsor: Peregrine Pharmaceuticals | Conditions: Glioblastoma Multiforme | Phase 2 | Status: COMPLETED